Proposed legislation takes aim at prescription drug advertising

New legislation recently introduced in the House of Representatives would direct the US Food and Drug Administration (FDA) to finalize a long-dormant final rule requiring pharmaceutical manufacturers to include a statement on drug labeling warning of a drug’s risks and side effects “in a clear, conspicuous, and neutral manner.”